Medium-dose anrikefon: Clinical Trials

2 trials of Medium-dose anrikefon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Terminated 1

Follow Medium-dose anrikefon: new trials by email Literature Review of Medium-dose anrikefon trials Research Report on Medium-dose anrikefon

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
High-dose anrikefon, Medium-dose anrikefon, Low-dose anrikefon - Laparoscopic Surgery, Visceral Pain, Postoperative
Phase 4RecruitingPeking University First Hospital1402026-04-142026-10-23
Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery
High-dose anrikefon, Medium-dose anrikefon, Low-dose anrikefon - Laparoscopic Surgery, Visceral Pain, Postoperative
Phase 4TerminatedPeking University First Hospital132025-12-252026-04-09

Conditions studied

Visceral Pain (2)

Sponsors

Peking University First Hospital (2)

Countries

China (2)

Top investigators

Dong-Xin Wang, MD, PhD (2)